Last updated on January 2010

Prostate Cancer


Brief description of study

Prostate Cancer

Detailed Study Description

To demonstrate superiority in the overall survival of patients with progressive prostate cancer.

Patient Inclusion Criteria:

  • Confirmed diagnosis of prostate cancer, patients must have surgical or ongoing chemical castration, patients must have disease that has failed one prior docetaxel-based chemotherapy regimen for the treatment of metastatic disease, disease progression

Patient Exclusion Criteria:

  • Prior treatment with sunitinib and more than one prior chemotherapy regimen in the metastatic disease treatment setting, chemotherapy within 3 weeks of the date of the first dose.

Clinical Study Identifier: TX134688

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Dr. Tom Davis

Legacy Pharma Research
Bismarck, ND USA
  Connect »